Retraction: The imprinted Igf2-Igf2r axis is critical for exosome biogenesis during the early development of bovine placenta
Journal of Reproduction and Development · 2025
DOI: 10.1262/jrd.2024-081 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Journal of Reproduction and Development, 2025. Verfasst von Kunhua Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Animal Science and Technology College, Beijing University of Agriculture, Beijing 102206, China. Hauptthemen laut MEDLINE: Exosomes, Insulin-Like Growth Factor II, Receptor, IGF Type 2, Placenta. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing University of Agriculture, Beijing Municipal Natural Science Foundation.
Abstract (Originalsprache)
Insulin-like growth factor 2 (IGF2) is essential for cell growth and differentiation and functions through the IGF2 receptor (IGF2R) to regulate embryonic and placental development. Exosomes that are synthesized and released from cells and play important roles in embryogenesis and placental development rely on the IGF2R for sorting and transport. However, the role of the imprinted Igf2-Igr2r axis and exosomes in the co-regulation of early placental development remains unknown. Cotyledon villi were collected from bovine placentas at different gestational ages, and the localization and expression of IGF2, IGF2R, and exosomal marker proteins were detected. Furthermore, the expression of exosomal marker factors was detected after the expression of IGF2R or IGF2 was inhibited through RNA interference or the addition of inhibitors, respectively. Our results demonstrated that IGF2, IGF2R, and the exosomal markers CD63, CD9, TSG101, and Rab11 are mainly located on the cell membrane of mononuclear trophoblast cells and binuclear trophoblast cells, which make up the cotyledon villi of the bovine placenta. The expressions of IGF2, IGF2R, and the exosomal marker proteins CD63, CD9, TSG101, and Rab11 showed a significant upward trend with increased gestation duration. Additionally, both Igf2r-knockdown and suppressing the expression of IGF2 with chromeceptin (IGF2 inhibitor) led to the downregulation of exosomal marker proteins in both bovine placental trophoblast cells (BTCs) and BTC-derived exosomes. Our study confirmed that the imprinted Igf2-Igf2r axis participates in the early development of cotyledon villi in the bovine placenta by manipulating exosome biogenesis, providing evidence for improving disorders during placental development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Animal Science and Technology College, Beijing University of Agriculture, Beijing 102206, China.
- Animal Epidemic prevention and Quarantine center, Huimin District, Inner Mongolia Autonomous Region 010030, China.
Förderung
- National Natural Science Foundation of China
- Beijing University of Agriculture
- Beijing Municipal Natural Science Foundation
Zitieren
APA
Zheng, K., Xiao, L., Yuan, N., Sheng, X., Qi, X., Wang, Y., Chen, C., Guo, K., Yang, L., Liu, B., & Wang, X. (2025). Retraction: The imprinted Igf2-Igf2r axis is critical for exosome biogenesis during the early development of bovine placenta. Journal of Reproduction and Development. https://doi.org/10.1262/jrd.2024-081
Vancouver
Zheng K, Xiao L, Yuan N, Sheng X, Qi X, Wang Y, et al. Retraction: The imprinted Igf2-Igf2r axis is critical for exosome biogenesis during the early development of bovine placenta. Journal of Reproduction and Development. 2025. doi:10.1262/jrd.2024-081
BibTeX
@article{Zheng2025,
author = {Zheng, Kunhua and Xiao, Longfei and Yuan, Naihan and Sheng, Xihui and Qi, Xiaolong and Wang, Yingqiu and Chen, Chang and Guo, Kaijun and Yang, Lin and Liu, Bingying and Wang, Xiangguo},
title = {Retraction: The imprinted Igf2-Igf2r axis is critical for exosome biogenesis during the early development of bovine placenta},
journal = {Journal of Reproduction and Development},
year = {2025},
doi = {10.1262/jrd.2024-081}
}
EUVIMED